Study guide · Area 1A
Providing Care: Clinical Care
50% of Part I · 5 competencies
Area 1A, Providing Care: Clinical Care, is about half of Part I (50% of the MCQ in PEBC's 2026 blueprint). It follows the patient care process: gather the information, assess it with the patient, build a plan, put it in place, then monitor and revise. Most questions are patient scenarios or short cases that ask for the best next step, the most appropriate therapy or the right monitoring.
A study feature written by ExamDragon, not part of the real exam. Each heading is one of this area's 5 competencies, as PEBC words it in the 2026 blueprint.
At a glance
Area 1Aof Part I, as PEBC weights it in the 2026 blueprint
- Weight
- 50%
- Competencies
- 5
- Key terms
- 9
What this guide covers, competency by competency
- 1.1Obtain relevant patient information
- 1.2Assess the patient's health status and unique needs, goals, and preferences, in partnership with the patient
- 1.3Develop a plan for the patient's care in collaboration with the patient and their circle of care
- 1.4Implement a plan for the patient's care in collaboration with the patient and their circle of care
- 1.5Monitor the patient and collaborate with the patient and their circle of care to revise the plan for the patient's care
1.1Obtain relevant patient information
- A best possible medication history uses at least two sources: the patient or caregiver interview plus a second source such as the pharmacy profile, the provincial drug information system, the medication vials or the prescriber's records.
- Ask about every kind of product: prescription, nonprescription, natural health products, vitamins, topical, inhaled, injected and eye or ear products, plus cannabis, alcohol, tobacco and other substances.
- Record allergies and intolerances with the reaction itself (for example hives, anaphylaxis, nausea), because a true allergy and a side effect lead to different decisions.
- Relevant data include age, weight, pregnancy or breastfeeding, kidney and liver function, recent labs with units, vital signs and the condition being treated.
- Open questions ("How do you take this medication?") reveal real use; closed questions confirm details such as dose and timing.
- For a self-care request, a structured approach (who is it for, what are the symptoms, how long, what has been tried, other conditions and medications) finds red flags that need referral.
- The situationAn 82-year-old man comes home from hospital with a discharge list. His daughter brings a bag of his medications from before admission.
- Step 1Interview the patient and daughter about what he actually takes, including nonprescription and natural products.
- Step 2Compare the bag, the discharge list and the pharmacy profile, line by line.
- Step 3List every difference (stopped, started, changed dose, duplicated) and clarify unexplained ones with the hospital prescriber.
- Where questions turnRelying on the pharmacy profile alone. It misses products bought elsewhere, samples, natural health products and medications the patient has stopped on their own.
- The takeawayMedication reconciliation needs more than one source, and every discrepancy is either explained or resolved.
1.2Assess the patient's health status and unique needs, goals, and preferences, in partnership with the patient
- Assessment means deciding whether each medication is indicated, effective, safe and taken as intended, and whether any condition is untreated.
- Common drug therapy problems: needs additional therapy, unnecessary therapy, wrong drug, dose too low, dose too high, adverse reaction or interaction, and nonadherence.
- Estimate kidney function before dosing renally cleared drugs. Cockcroft-Gault in SI units: CrCl (mL/min) = (140 minus age) x weight (kg) x 1.23 for males or 1.04 for females, divided by serum creatinine (mcmol/L).
- Older adults are more sensitive to anticholinergic, sedative and blood pressure lowering effects; falls, confusion and constipation are often drug related.
- Red flags in self-care (for example chest pain, blood in stool, severe or sudden headache, fever with stiff neck, symptoms lasting beyond the expected time) mean referral, not a nonprescription product.
- The patient's goals, values, beliefs and ability to pay or manage a regimen are part of the assessment, not an afterthought.
- The situationA 70-year-old woman weighing 60 kg has a serum creatinine of 120 mcmol/L. A renally cleared antibiotic is prescribed at full dose.
- Step 1Calculate CrCl: (140 minus 70) x 60 x 1.04 / 120 = 36 mL/min.
- Step 2Check the product monograph for the dose adjustment at that level of kidney function.
- Step 3If the dose is too high for her kidney function, contact the prescriber with the calculation and a suggested dose.
- Where questions turnTreating every symptom with a product. Assessment comes first, and sometimes the best answer is referral or no drug at all.
- The takeawayA normal-looking serum creatinine can hide reduced kidney function in a small, older patient; calculate before you accept the dose.
1.3Develop a plan for the patient's care in collaboration with the patient and their circle of care
- A plan sets goals of therapy that are specific and measurable (for example a blood pressure target, an A1C target, symptom relief by a set day).
- Choose therapy by efficacy, safety for this patient, interactions, convenience, cost and coverage, and the patient's preference.
- Diabetes Canada guidance: metformin is the usual first agent for type 2 diabetes when there is no contraindication, and agents with proven cardiorenal benefit are added for patients with cardiovascular disease, heart failure or chronic kidney disease.
- Combining an ACE inhibitor with an angiotensin receptor blocker is not recommended for hypertension because it raises the risk of high potassium and kidney injury without added benefit.
- Nonpharmacological measures (diet, activity, sleep, smoking cessation, alcohol reduction) belong in the plan alongside drugs.
- Every plan says who does what, when follow-up happens and what will be monitored.
- The situationA 54-year-old man with newly diagnosed type 2 diabetes, normal kidney function and no cardiovascular disease asks what happens next. His A1C is 7.8%.
- Step 1Agree on a goal with him: an A1C of 7.0% or less is the usual target for most adults.
- Step 2Recommend lifestyle measures and metformin, started low and increased gradually to limit stomach upset.
- Step 3Set follow-up: review tolerance in a few weeks and recheck A1C in about three months.
- Where questions turnChoosing the newest or strongest drug without checking the patient's other conditions, coverage and preferences.
- The takeawayA good plan has a measurable goal, a reasoned first choice and a date to check whether it worked.
1.4Implement a plan for the patient's care in collaboration with the patient and their circle of care
- Implementing a plan means dispensing or recommending therapy, educating the patient, arranging coverage and communicating the plan to the circle of care.
- Counselling covers the name and purpose, how and when to take it, what to expect and when, common and serious side effects, what to do about a missed dose, storage and when to seek help.
- Teach-back (asking the patient to explain or show in their own words) confirms understanding better than asking "Do you have any questions?".
- Device technique (inhalers, insulin pens, eye drops, nasal sprays) is shown and then watched; poor technique is a common reason a drug seems not to work.
- Alendronate is taken first thing in the morning with a full glass of plain water, at least 30 minutes before food, drink or other medications, and the patient stays upright for at least 30 minutes.
- Levothyroxine is taken on an empty stomach, separated by about four hours from calcium, iron and antacids, which reduce its absorption.
- The situationA 35-year-old woman with asthma is starting a combination inhaled corticosteroid and long-acting beta agonist inhaler.
- Step 1Explain what the inhaler does and that the corticosteroid works over days to weeks.
- Step 2Demonstrate the technique, then watch her use a placebo or her own device and correct errors.
- Step 3Advise rinsing the mouth after use to reduce the risk of oral thrush, and confirm understanding with teach-back.
- Where questions turnGiving a long list of every possible side effect. Focus on what is common, what is serious and what the patient should do.
- The takeawayImplementation is complete only when the patient can do it correctly, not when the information has been said.
1.5Monitor the patient and collaborate with the patient and their circle of care to revise the plan for the patient's care
- Monitoring checks both effectiveness (is the goal being met?) and safety (adverse effects, labs, interactions, adherence).
- Warfarin: the usual INR target is 2.0 to 3.0 for atrial fibrillation and venous thromboembolism; interacting drugs and changes in diet or illness call for closer INR checks.
- After starting an ACE inhibitor or angiotensin receptor blocker, check potassium and serum creatinine within about one to two weeks.
- Lithium levels rise with dehydration and with NSAIDs, thiazide diuretics and ACE inhibitors; signs of toxicity include tremor, confusion, vomiting and unsteadiness.
- Statins: ask about unexplained muscle pain or weakness; simvastatin with strong CYP3A4 inhibitors such as clarithromycin is contraindicated because of the risk of muscle injury.
- When the goal is not met, look first at adherence, technique and interactions before increasing the dose or adding a drug.
- The situationA 66-year-old man on warfarin for atrial fibrillation, INR stable at 2.4, is prescribed a course of an interacting antibiotic.
- Step 1Identify the interaction and the likely direction (a rise in INR).
- Step 2Contact the prescriber to suggest an alternative antibiotic or, if the course is needed, arrange an INR check within a few days.
- Step 3Tell the patient the signs of bleeding to watch for and record the plan and follow-up date.
- Where questions turnAdding a second drug when the first one is not working, without first checking whether the patient is taking the first one as intended.
- The takeawayMonitoring is planned in advance: what to check, when, by whom, and what result changes the plan.
Key terms
- BPMH
- Best possible medication history: a complete list of the medications a patient actually takes, from at least two sources.
- Medication reconciliation
- Comparing medication lists at transitions of care and resolving every discrepancy.
- Drug therapy problem
- An actual or potential problem with a medication that interferes with the patient's goals of therapy.
- CrCl
- Creatinine clearance, an estimate of kidney function used to adjust doses of renally cleared drugs.
- eGFR
- Estimated glomerular filtration rate, reported by labs to stage chronic kidney disease.
- INR
- International normalized ratio, the test used to monitor warfarin.
- A1C
- Glycated hemoglobin, a measure of average blood glucose over about three months.
- Teach-back
- Asking the patient to explain or demonstrate in their own words to confirm understanding.
- Red flag
- A symptom or sign that calls for referral to another health professional instead of self-care.
Show the answer
(140 minus 78) x 50 x 1.04 / 100 = 32 mL/min, about 32 mL/min.
Built to PEBC's 2026 Qualifying Examination blueprint. The explanations, worked examples and traps are ExamDragon's own. Every source this path is built on.
